• Info
  • Insider Ownership

Insider Trading & Ownership of Versant Venture Capital VII, L.P.

Location
San Francisco, CA
Summary
The estimated value of insider holdings of Versant Venture Capital VII, L.P. is at least $120,217,268 dollars as of 25 Mar 2024. Versant Venture Capital VII, L.P. is the 10%+ Owner of CHINOOK THERAPEUTICS, INC. and owns shares of CHINOOK THERAPEUTICS, INC. stock worth about $113.69M. Versant Venture Capital VII, L.P. is the 10%+ Owner of LENZ Therapeutics, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $6.52M.
Signature
Versant Venture Capital VII, L.P. By: Versant Ventures VII GP, L.P. Its: General Partner By: Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer
All Insider Reports
All Insider Reports

Notify me when Versant Venture Capital VII, L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Versant Venture Capital VII, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KDNY CHINOOK THERAPEUTICS, INC. 10%+ Owner $113,694,209 04 Apr 2022
LENZ LENZ Therapeutics, Inc. 10%+ Owner $6,523,059 21 Mar 2024

Insider Transactions Reported by Versant Venture Capital VII, L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.